Lifestyles and Cardiovascular Prevention in Childhood and Adolescence.


Journal

Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 11 05 2019
accepted: 10 07 2019
pubmed: 26 7 2019
medline: 29 10 2019
entrez: 26 7 2019
Statut: ppublish

Résumé

Pathology studies demonstrated that coronary fatty streaks develop early in life and that even more advanced fibrous plaques are present in a proportion of adolescents. The presence and extent of atherosclerosis in children and adolescents can be correlated with the same risk factors present in adults; as well as, childhood levels of these risk factors predict adult cardiovascular diseases. Children are born with ideal cardiovascular health but, unfortunately, most of them develop over time modifiable behavioral risk factors. Achieving sustained lifestyle changes initiated too late in adults is difficult, and pharmacologic risk factor control cannot fully restore a low-risk state. Therefore, it seems eminently reasonable to initiate healthful lifestyle training as early in life, decreasing the prevalence of cardiovascular risk factors to retard atherogenic processes and reduce the future burden of cardiovascular diseases. Many guideline recommendations encourage universal adoption of healthier lifestyles, identification of children with cardiovascular risk factors, and their treatment using targeted lifestyle modification and, rarely, pharmacotherapy. Major gains will likely accrue from public health strategies targeting incorrect diet, physical activity, and cigarette smoking. Individualized strategies, however, will initially focus on the highest risk children such as those with familial hyperlipidaemia, diabetes, hypertension, and obesity. The primary purpose of this article is to provide a broad overview on the long-term cardiovascular effects of risk factors in children and youth and to outline various lines of evidence for the efficacy of primordial and primary prevention in young people, as well as recommendations for population- and individual-level strategies and evidence-based interventions.

Identifiants

pubmed: 31342115
doi: 10.1007/s00246-019-02152-w
pii: 10.1007/s00246-019-02152-w
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1113-1125

Références

N Engl J Med. 2004 Jun 3;350(23):2362-74
pubmed: 15175438
Ital Heart J Suppl. 2004 May;5(5):398-412
pubmed: 15182068
Am J Cardiol. 2005 Jan 1;95(1):150-2
pubmed: 15619417
Heart. 2006 Nov;92(11):1701-6
pubmed: 17041125
Circulation. 2007 Aug 28;116(9):973-4
pubmed: 17724270
J Pediatr Gastroenterol Nutr. 2008 Jan;46(1):99-110
pubmed: 18162844
Pediatrics. 2009 Jan;123(1):e67-73
pubmed: 19117849
Pediatr Cardiol. 2009 May;30(4):477-81
pubmed: 19322601
J Hypertens. 2009 Sep;27(9):1719-42
pubmed: 19625970
Ann Med. 2011 Jun;43(4):312-9
pubmed: 21284533
J Pediatr Endocrinol Metab. 2011;24(1-2):51-4
pubmed: 21528815
Nat Rev Cardiol. 2011 Jun 14;8(9):513-25
pubmed: 21670745
Kardiol Pol. 2011;69(6):540-5
pubmed: 21678286
Pediatr Cardiol. 2012 Feb;33(2):222-8
pubmed: 21915719
Pediatrics. 2011 Dec;128 Suppl 5:S213-56
pubmed: 22084329
Eur J Prev Cardiol. 2013 Apr;20(2):301-9
pubmed: 22345689
JAMA. 1990 Dec 19;264(23):3018-24
pubmed: 2243430
J Am Soc Echocardiogr. 2012 Oct;25(10):1075-82
pubmed: 22858246
Nutrition. 2013 Feb;29(2):379-86
pubmed: 23022122
Ital J Pediatr. 2012 Dec 21;38:73
pubmed: 23259704
J Epidemiol Community Health. 2013 May;67(5):405-11
pubmed: 23322856
CMAJ. 2013 Aug 6;185(11):E531-6
pubmed: 23775611
J Am Coll Cardiol. 2014 Feb 4;63(4):369-71
pubmed: 24076288
Psychosom Med. 2014 Feb;76(2):122-7
pubmed: 24470130
Science. 2014 Mar 28;343(6178):1478-85
pubmed: 24675955
J Am Heart Assoc. 2014 Apr 22;3(2):e000594
pubmed: 24755150
Circulation. 2015 Jan 20;131(3):245-53
pubmed: 25583139
PLoS One. 2015 Apr 08;10(4):e0121183
pubmed: 25853242
Curr Cardiol Rep. 2015 Oct;17(10):88
pubmed: 26289252
Health Behav Policy Rev. 2014 Nov;1(6):472-483
pubmed: 26523282
Hypertension. 2015 Dec;66(6):1108-15
pubmed: 26558818
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
Circulation. 2016 Sep 20;134(12):e236-55
pubmed: 27515136
JAMA. 2016 Aug 9;316(6):625-33
pubmed: 27532917
Circulation. 2016 Oct 18;134(16):e336-e359
pubmed: 27619923
Br J Sports Med. 2016 Dec;50(23):1451-1458
pubmed: 27670254
Curr Allergy Asthma Rep. 2017 Aug;17(8):55
pubmed: 28741144
Pediatrics. 2017 Sep;140(3):null
pubmed: 28827377
Int J Cardiol. 2018 Mar 1;254:303-309
pubmed: 29221862
Circulation. 2018 Jan 30;137(5):e15-e28
pubmed: 29254928
Curr Pediatr Rev. 2017;13(4):255-259
pubmed: 29345597
Int J Cardiol. 2018 May 1;258:289-294
pubmed: 29428239
J Am Heart Assoc. 2018 Apr 13;7(8):
pubmed: 29654202
Child Obes. 2018 May/Jun;14(4):207-217
pubmed: 29762052
PLoS One. 2018 Jun 1;13(6):e0197922
pubmed: 29856786
Congenit Heart Dis. 2018 Jul;13(4):563-570
pubmed: 29938932
Public Health Nutr. 2018 Oct;21(14):2642-2653
pubmed: 29947308
Ann Behav Med. 2018 Jul 13;52(8):621-632
pubmed: 30010703
Int J Cardiol. 2018 Dec 1;272:333-340
pubmed: 30017513
Int J Cardiol. 2018 Oct 15;269:339-342
pubmed: 30057162
N Engl J Med. 1998 Jun 4;338(23):1650-6
pubmed: 9614255

Auteurs

Maurizio Giuseppe Abrignani (MG)

O.U. of Cardiology, P.O. S. Antonio Abate Di Trapani, ASP Trapani, Via F. Crispi 6, 91025, Marsala, Italy. maur.abri@alice.it.

Fabiana Lucà (F)

O.U. of Cardiology, Grande Ospedale Metropolitano, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy.

Silvia Favilli (S)

O.U. of Cardiology, A.O.U. Meyer, Florence, Italy.

Manuela Benvenuto (M)

O.U. of Cardiology, Ospedale Civile Giuseppe Mazzini, Teramo, Italy.

Carmelo Massimiliano Rao (CM)

O.U. of Cardiology, Grande Ospedale Metropolitano, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy.

Stefania Angela Di Fusco (SA)

O.U. of Cardiology, P.O. S. Filippo Neri, Rome, Italy.

Domenico Gabrielli (D)

O.U. of Cardiology, Ospedale Civile A. Murri, Fermo, Italy.

Michele Massimo Gulizia (MM)

O.U. of Cardiology, P.O. Garibaldi Nesima, Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH